A key reason positions haven't been filled is that they require travel that ranges from 25% to 75% of the time.
Learn how DLA, GSA’s Federal Acquisition Service and the State Department are modernizing their contract and acquisition ...
"Severe neutropenia occurs in a small percentage of patients taking clozapine; however, neutropenia is associated with an ...
“FDA has not yet developed action plans to fully address travel, workload, and work-life balance because potential solutions ...
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
The FDA designated 166 products under its breakthrough devices program in its most recent financial year, reversing the ...
Dallas Morning News on MSN8d
FDA adds new warning to weight loss drugs including WegovyThe FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...
GlobalData on MSN29d
FDA revokes EUA for Cue Health’s Covid-19 tests tagging recall as Class IIThe FDA expanded the test label to include home and OTC use in March 2021. A Class II recall is issued by the FDA when it ...
The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback